Cargando…

Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis

Rheumatoid arthritis (RA), one of the most common immune system diseases, mainly affects middle-aged and elderly individuals and has a serious impact on the quality of life of patients. Pain and disability caused by RA are significant symptoms negatively affecting patients, and they are especially s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Kai, Jiang, Ping, Zhao, Jianan, Jin, Yehua, Zhang, Runrun, Chang, Cen, Xu, Lingxia, Xu, Linshuai, Shi, Yiming, Guo, Shicheng, He, Dongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995470/ https://www.ncbi.nlm.nih.gov/pubmed/35418971 http://dx.doi.org/10.3389/fimmu.2022.865267

Ejemplares similares

Metabolomics in rheumatoid arthritis: Advances and review
por: Xu, Lingxia, et al.
Publicado: (2022)

MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis
por: Chang, Cen, et al.
Publicado: (2022)

SFRP1 Negatively Modulates Pyroptosis of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis: A Review
por: Jiang, Ping, et al.
Publicado: (2022)

DNA methylation change of HIPK3 in Chinese rheumatoid arthritis and its effect on inflammation
por: Jiang, Ping, et al.
Publicado: (2023)

G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles
por: Zhao, Jianan, et al.
Publicado: (2022)

Epigenetic Regulation Mediated by Methylation in the Pathogenesis and Precision Medicine of Rheumatoid Arthritis
por: Guo, Shicheng, et al.
Publicado: (2020)

Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis
por: Shi, Yiming, et al.
Publicado: (2023)

Circulating methylation level of HTR2A is associated with inflammation and disease activity in rheumatoid arthritis
por: Zhao, Jianan, et al.
Publicado: (2022)

Therapeutic Effects of (5R)-5-Hydroxytriptolide on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via lncRNA WAKMAR2/miR-4478/E2F1/p53 Axis
por: Zhou, Xinpeng, et al.
Publicado: (2021)

DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
por: Zhao, Jianan, et al.
Publicado: (2022)

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications
por: Zhao, Jianan, et al.
Publicado: (2022)

Identification of DNA methylation-regulated differentially expressed genes in RA by integrated analysis of DNA methylation and RNA-Seq data
por: Zhang, Runrun, et al.
Publicado: (2022)

Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application
por: Zheng, Yixin, et al.
Publicado: (2023)

Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis
por: Zhao, Jianan, et al.
Publicado: (2023)

RNA-seq and Network Analysis Reveal Unique Chemokine Activity Signatures in the Synovial Tissue of Patients With Rheumatoid Arthritis
por: Zhang, Runrun, et al.
Publicado: (2022)

Circulating Level of Blood Iron and Copper Associated with Inflammation and Disease Activity of Rheumatoid Arthritis
por: Wang, Huijuan, et al.
Publicado: (2022)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Zhao, Jianan, et al.
Publicado: (2021)

Cuproptosis and cuproptosis–related genes in rheumatoid arthritis: Implication, prospects, and perspectives
por: Zhao, Jianan, et al.
Publicado: (2022)

Identification of biomarkers in patients with rheumatoid arthritis responsive to DMARDs but with progressive bone erosion
por: Marasco, Emiliano, et al.
Publicado: (2023)

Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
por: Zhao, Jianan, et al.
Publicado: (2021)

Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis
por: Shan, Yu, et al.
Publicado: (2023)

Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives
por: Zheng, Yixin, et al.
Publicado: (2023)

Case report: Whole exome sequencing and genome-wide methylation profiling of Czech dysplasia in a Chinese pedigree
por: Zhao, Mengfei, et al.
Publicado: (2023)

Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue
por: Triaille, Clement, et al.
Publicado: (2021)

A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions
por: Shan, Yu, et al.
Publicado: (2023)

Multidrug resistance proteins and DMARD efficacy in rheumatoid arthritis
por: Jansen, G, et al.
Publicado: (2004)

Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone
por: Edwards, Carl K., et al.
Publicado: (2012)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler, Eduardo, et al.
Publicado: (2021)

Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients
por: Karadeniz, Hazan, et al.
Publicado: (2022)

Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications
por: Zhao, Jianan, et al.
Publicado: (2022)

MicroRNA Variants and HLA-miRNA Interactions are Novel Rheumatoid Arthritis Susceptibility Factors
por: Guo, Shicheng, et al.
Publicado: (2021)

Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
por: Fan, Junyu, et al.
Publicado: (2023)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Delayed conventional DMARDs therapy is effective in Rheumatoid Arthritis
por: Ahsan, Tasnim, et al.
Publicado: (2017)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021)

Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis: A network meta-analysis
por: Wang, Zunlian, et al.
Publicado: (2021)

Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review
por: Zago, Basiru Ahmad, et al.
Publicado: (2020)

Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2023)

Toward Overcoming Treatment Failure in Rheumatoid Arthritis
por: Wang, Zhuqian, et al.
Publicado: (2021)

Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time‐series analysis
por: Fang, Yao‐Fan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l23il3hd19uv9amjptlmsam8om